Picture of AstraZeneca logo

AZN — AstraZeneca News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Insitro Announces a Strategic Collaboration with AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies

BRIEF-Insitro Announces a Strategic Collaboration with AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies

- AstraZeneca PLC AZN.L:

  • INSITRO ANNOUNCES A STRATEGIC COLLABORATION WITH ASTRAZENECA FOR AI-ENABLED DISCOVERY OF NOVEL THERAPEUTICS FOR MASH AND CARDIOMYOPATHIES

  • INSITRO: UNDER TERMS, CO TO RECEIVE $40 MILLION UPFRONT, ELIGIBLE FOR UP TO ABOUT $1.46 BILLION IN POTENTIAL DISCOVERY, DEVELOPMENT, & COMMERCIAL MILESTONES

Source text: ID:nBwb83FNDa

Further company coverage: AZN.L


((Reuters.Briefs@thomsonreuters.com;))

Recent news on AstraZeneca

See all news